NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company.
 
Status Discontinued
Decision Selected
Process MT
ID number 310

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
27 March 2017 Discontinued. NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company.

For further information on our processes and methods, please see our CHTE processes and methods manual